A federal appeals court in New Orleans is expected to weigh in on whether a commonly used pill, mifepristone, should remain widely available. Here is what’s at stake.
The U.S. Court of Appeals for the Fifth Circuit has long been at the center of high-profile challenges, and a wave of Trump appointees has pushed it to the leading edge of potent policy decisions.